These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 19930311)

  • 1. AEB071--a promising immunosuppressive agent.
    Sommerer C; Zeier M
    Clin Transplant; 2009 Dec; 23 Suppl 21():15-8. PubMed ID: 19930311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sotrastaurin, a protein kinase C inhibitor for the prevention of transplant rejection and treatment of psoriasis.
    Manicassamy S
    Curr Opin Investig Drugs; 2009 Nov; 10(11):1225-35. PubMed ID: 19876790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationship and pharmacokinetic studies of sotrastaurin (AEB071), a promising novel medicine for prevention of graft rejection and treatment of psoriasis.
    Wagner J; von Matt P; Faller B; Cooke NG; Albert R; Sedrani R; Wiegand H; Jean C; Beerli C; Weckbecker G; Evenou JP; Zenke G; Cottens S
    J Med Chem; 2011 Sep; 54(17):6028-39. PubMed ID: 21797275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the novel protein kinase C inhibitor sotrastaurin as immunosuppressive therapy after renal transplantation.
    Matz M; Naik M; Mashreghi MF; Glander P; Neumayer HH; Budde K
    Expert Opin Drug Metab Toxicol; 2011 Jan; 7(1):103-13. PubMed ID: 21142580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potent protein kinase C-selective inhibitor AEB071 (sotrastaurin) represents a new class of immunosuppressive agents affecting early T-cell activation.
    Evenou JP; Wagner J; Zenke G; Brinkmann V; Wagner K; Kovarik J; Welzenbach KA; Weitz-Schmidt G; Guntermann C; Towbin H; Cottens S; Kaminski S; Letschka T; Lutz-Nicoladoni C; Gruber T; Hermann-Kleiter N; Thuille N; Baier G
    J Pharmacol Exp Ther; 2009 Sep; 330(3):792-801. PubMed ID: 19491325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the new immunosuppressive agent AEB071 on human immune cells.
    Matz M; Weber U; Mashreghi MF; Lorkowski C; Ladhoff J; Kramer S; Neumayer HH; Budde K
    Nephrol Dial Transplant; 2010 Jul; 25(7):2159-67. PubMed ID: 20100729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overview of sotrastaurin clinical pharmacokinetics.
    Kovarik JM; Slade A
    Ther Drug Monit; 2010 Oct; 32(5):540-3. PubMed ID: 20683390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of AEB071 (sotrastaurin) with tacrolimus on rat heterotopic cardiac allograft rejection and survival.
    Fang YH; Joo DJ; Lim BJ; Huh KH; Kim MS; Suh H; Kim YS
    J Surg Res; 2011 Nov; 171(1):e133-7. PubMed ID: 21816421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sotrastaurin (AEB071) alone and in combination with cyclosporine A prolongs survival times of non-human primate recipients of life-supporting kidney allografts.
    Bigaud M; Wieczorek G; Beerli C; Audet M; Blancher A; Heusser C; Morris RE; Wagner J
    Transplantation; 2012 Jan; 93(2):156-64. PubMed ID: 22179400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the novel protein kinase C inhibitor AEB071 (Sotrastaurin) on rat cardiac allograft survival using single agent treatment or combination therapy with cyclosporine, everolimus or FTY720.
    Weckbecker G; Pally C; Beerli C; Burkhart C; Wieczorek G; Metzler B; Morris RE; Wagner J; Bruns C
    Transpl Int; 2010 May; 23(5):543-52. PubMed ID: 20003043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of 3-(1H-indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione (AEB071), a potent and selective inhibitor of protein kinase C isotypes.
    Wagner J; von Matt P; Sedrani R; Albert R; Cooke N; Ehrhardt C; Geiser M; Rummel G; Stark W; Strauss A; Cowan-Jacob SW; Beerli C; Weckbecker G; Evenou JP; Zenke G; Cottens S
    J Med Chem; 2009 Oct; 52(20):6193-6. PubMed ID: 19827831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for immunosuppression in lung transplantation.
    Hopkins PM; McNeil K
    Curr Opin Organ Transplant; 2008 Oct; 13(5):477-83. PubMed ID: 19060529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic allograft dysfunction: can we use mammalian target of rapamycin inhibitors to replace calcineurin inhibitors to preserve graft function?
    Wali RK; Weir MR
    Curr Opin Organ Transplant; 2008 Dec; 13(6):614-21. PubMed ID: 19060552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppressive strategies to improve outcomes of kidney transplantation.
    Tang IY; Meier-Kriesche HU; Kaplan B
    Semin Nephrol; 2007 Jul; 27(4):377-92. PubMed ID: 17616271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive agents in organ transplantation: past, present, and future.
    Hong JC; Kahan BD
    Semin Nephrol; 2000 Mar; 20(2):108-25. PubMed ID: 10746855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase C inhibitor, AEB-071, acts complementarily with cyclosporine to prevent islet rejection in rats.
    Merani S; Pawlick RL; Edgar RL; Toso C; Emamaullee J; Anderson CC; Shapiro AM
    Transplantation; 2009 Jan; 87(1):59-65. PubMed ID: 19136892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FK778 ameliorates post-transplant expression of fibrogenic growth factors and development of chronic rejection changes in rat kidney allografts.
    Rintala JM; Savikko J; Rintala SE; von Willebrand E
    Nephrol Dial Transplant; 2008 Nov; 23(11):3446-55. PubMed ID: 18558624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal transplantation, past, present and future.
    Ponticelli C; Tarantino A; Vegeto A
    J Nephrol; 1999; 12 Suppl 2():S105-10. PubMed ID: 10688409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tofacitinib in kidney transplantation.
    Wojciechowski D; Vincenti F
    Expert Opin Investig Drugs; 2013 Sep; 22(9):1193-9. PubMed ID: 23841583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel immunosuppression: small molecules and biologics.
    Yabu JM; Vincenti F
    Semin Nephrol; 2007 Jul; 27(4):479-86. PubMed ID: 17616278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.